Novavax COVID-19 Vaccine Receives FDA EUA for Ages 12 to 17

Novavax

Novamax Inc. announced the U.S. Food and Drug Administration (FDA) granted its COVID-19 vaccine, NVX-CoV2373, emergency usage authorization (EUA) for youth ages 12 to 17 on Friday. Last month, the company received emergency approval for adults 18 and older. FDA Commissioner Robert M. Califf, M.D. said: “Authorizing an additional COVID-19 vaccine expands the available options […]